|
시장보고서
상품코드
1586347
헤파린 칼슘 시장, 규모, 점유율, 동향, 산업 분석 보고서 : 유형별, 용도별, 유통 채널별, 지역별 - 시장 예측(2024-2032년)Heparin Calcium Market Size, Share, Trends, Industry Analysis Report: By Type, Application, Distribution Channel, and By Region - Market Forecast, 2024-2032 |
||||||
Polaris Market Research의 최신 조사에 따르면, 세계 헤파린 칼슘 시장 규모는 2032년까지 19억 9,999만 달러에 달할 것으로 예상됩니다. 이 보고서는 현재 시장 역학에 대한 자세한 통찰력과 미래 시장 성장에 대한 분석을 제공합니다.
헤파린 칼슘 시장의 성장을 주도하는 것은 치료 목적의 사용 증가와 항응고 요법을 필요로 하는 만성 질환의 유병률 증가입니다. 심혈관 및 정형외과 수술에서 헤파린의 사용 확대, 의약품 제조의 발전, 치료 효과에 대한 인식 증가 등의 요인이 시장 성장을 견인하고 있습니다.
새로운 제형에 대한 지속적인 연구와 보다 효율적인 생산 공정의 개발은 향후 몇 년동안 시장에 유리한 기회를 제공할 것으로 예상됩니다. 향후 시장 동향은 헤파린 제품의 품질과 안전성에 대한 관심이 높아지면서 신흥 시장에서 수요가 증가할 것으로 예상됩니다. 전반적으로, 의료 서비스 제공업체가 첨단 치료법을 계속 채택하고 약물 전달 시스템의 기술 혁신이 진행됨에 따라 시장이 확대될 것으로 예상됩니다.
헤파린 칼슘 시장 보고서 하이라이트
유형별로는 저분자 헤파린(LMWH) 부문이 미분획 헤파린에 비해 향상된 안전성 프로파일과 사용 편의성으로 인해 시장을 주도하고 있으며, LMWH는 출혈성 합병증 위험이 낮고 예측 가능한 용량 반응으로 인해 선호되고 있습니다.
심부정맥혈전증(DVT) 분야는 높은 유병률과 효과적인 항응고 요법에 대한 중요한 요구로 인해 용도별 시장 점유율이 가장 높은 분야이며, DVT 예방 치료에 대한 관심이 높아지면서 이 분야의 성장을 뒷받침하고 있습니다.
유통 채널별로는 병원 약국이 시장을 주도하고 있습니다. 이 우위는 즉각적이고 대량 공급에 대한 의료기관의 직접적인 수요에 기인합니다. 그러나 온라인 약국 부문은 디지털 헬스케어 솔루션으로의 전환과 환자 접근성 증가를 반영하여 가장 빠르게 성장하는 채널입니다.
북미는 높은 수준의 의료 인프라와 항응고제 치료에 대한 높은 수요로 인해 가장 큰 시장 점유율을 차지하고 있습니다. 반면, 아시아태평양은 헬스케어 투자 증가와 심혈관 질환에 대한 인식 증가로 인해 가장 빠르게 성장하는 지역입니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 세계의 헤파린 칼슘 시장 인사이트
- 시장 현황
- 헤파린 칼슘 시장 역학
- 성장 촉진요인과 기회
- 성장 억제요인과 과제
- PESTEL 분석
- 헤파린 칼슘 시장 용도 동향
- 밸류체인 분석
- COVID-19의 영향 분석
제5장 세계의 헤파린 칼슘 시장 : 유형별
- 주요 조사 결과
- 서론
- 미분화 헤파린
- 저분자량 헤파린
제6장 세계의 헤파린 칼슘 시장 : 용도별
- 주요 조사 결과
- 서론
- 신장 투석
- 심방세동
- 심부정맥 혈전증
- 폐색전증
- 기타
제7장 세계의 헤파린 칼슘 시장 : 유통 채널별
- 주요 조사 결과
- 서론
- 병원 약국
- 소매 약국
- 온라인 약국
제8장 세계의 헤파린 칼슘 시장 : 지역별
- 주요 조사 결과
- 서론
- 헤파린 칼슘 시장 평가 : 지역별, 2019년-2032년
- 북미
- 북미 : 유형별, 2019년-2032년
- 북미 : 용도별, 2019년-2032년
- 북미 : 유통 채널별, 2019년-2032년
- 미국
- 캐나다
- 유럽
- 유럽 : 유형별, 2019년-2032년
- 유럽 : 용도별, 2019년-2032년
- 유럽 : 유통 채널별, 2019년-2032년
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 유형별, 2019년-2032년
- 아시아태평양 : 용도별, 2019년-2032년
- 아시아태평양 : 유통 채널별, 2019년-2032년
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 유형별, 2019년-2032년
- 중동 및 아프리카 : 용도별, 2019년-2032년
- 중동 및 아프리카 : 유통 채널별, 2019년-2032년
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 유형별, 2019년-2032년
- 라틴아메리카 : 용도별, 2019년-2032년
- 라틴아메리카 : 유통 채널별, 2019년-2032년
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제9장 경쟁 구도
- 확대와 인수 분석
- 확대
- 인수
- 제휴/협업/합의/공개
제10장 기업 개요
- Pfizer Inc.
- Sanofi S.A.
- Leo Pharma A/S
- Teva Pharmaceutical Industries Ltd.
- Sandoz(a division of Novartis)
- Fresenius Kabi
- Baxter International Inc.
- Aspen Pharmacare
- B. Braun Melsungen AG
- Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
- Hikma Pharmaceuticals PLC
- Dr. Reddy's Laboratories
- Cipla Limited
- Bioiberica S.A.U.
- Troikaa Pharmaceuticals Ltd.
The global heparin calcium market size is expected to reach USD 1,999.99 million by 2032, according to a new study by Polaris Market Research. The report "Heparin Calcium Market Size, Share, Trends, Industry Analysis Report: By Type (Unfractionated Heparin and Low Molecular Weight Heparin), Application (Kidney Dialysis, Atrial Fibrillation, Deep Vein Thrombosis, Pulmonary Embolism, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2024-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The heparin calcium market growth is driven by increasing applications in medical treatments and a rising prevalence of chronic diseases that require anticoagulant therapies. Factors such as expanding use of heparin in cardiovascular and orthopedic procedures, advancements in pharmaceutical manufacturing, and heightened awareness of its therapeutic benefits boost the market growth.
Ongoing research in novel formulations and the development of more efficient production processes are expected to offer lucrative opportunities for the market in the coming years. Future trends in the market are growing emphasis on the quality and safety of heparin products and the potential for increased demand from emerging markets. Overall, the market is set to expand as healthcare providers continue to adopt advanced treatments and as innovations in drug delivery systems progress.
Heparin Calcium Market Report Highlights:
In terms of type, the low molecular weight heparin (LMWH) segment dominates the market due to its enhanced safety profile and ease of use compared to unfractionated heparin. LMWH is preferred for its lower risk of bleeding complications and more predictable dose response.
The deep vein thrombosis (DVT) segment, by application, holds the largest market share, driven by its high prevalence and critical need for effective anticoagulant therapy. The growing focus on preventive treatments for DVT also supports this segment's growth.
Based on distribution channel, the hospital pharmacies segment is leading the market. The dominance is attributed to the direct demand from medical institutions for immediate and large-volume supplies. However, the online pharmacies segment is the fastest-growing channel, reflecting a shift toward digital healthcare solutions and increased patient access.
North America holds the largest market share due to advanced healthcare infrastructure and high demand for anticoagulant treatments. Asia Pacific, on the other hand, is the fastest-growing region, driven by increasing healthcare investments and rising awareness about cardiovascular diseases.
Polaris Market Research has segmented the heparin calcium market report on the basis of type, application, distribution channel, and region:
By Type Outlook (Revenue - USD million, 2019-2032)
Unfractionated Heparin
Low Molecular Weight Heparin
By Application Outlook (Revenue - USD million, 2019-2032)
Kidney Dialysis
Atrial Fibrillation
Deep Vein Thrombosis
Pulmonary Embolism
Others
By Distribution Channel Outlook (Revenue - USD million, 2019-2032)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Regional Outlook (Revenue - USD million, 2019-2032)
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Heparin Calcium Market Insights
- 4.1. Heparin Calcium Market - Market Snapshot
- 4.2. Heparin Calcium Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing Demand Due to Rising Prevalence of Cardiovascular Diseases
- 4.2.1.2. Shift Toward Subcutaneous Formulations
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Regulatory Challenges is hindering the Heparin Calcium market growth
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Heparin Calcium Market Application Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Heparin Calcium Market, by Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Heparin Calcium Market, by Type, 2019-2032 (USD million)
- 5.3. Unfractionated Heparin
- 5.3.1. Global Heparin Calcium Market, by Unfractionated Heparin, by Region, 2019-2032 (USD million)
- 5.4. Low Molecular Weight Heparin
- 5.4.1. Global Heparin Calcium Market, by Low Molecular Weight Heparin, by Region, 2019-2032 (USD million)
6. Global Heparin Calcium Market, by Application
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Heparin Calcium Market, by Application, 2019-2032 (USD million)
- 6.3. Kidney Dialysis
- 6.3.1. Global Heparin Calcium Market, by Kidney Dialysis, by Region, 2019-2032 (USD million)
- 6.4. Atrial Fibrillation
- 6.4.1. Global Heparin Calcium Market, by Atrial Fibrillation, by Region, 2019-2032 (USD million)
- 6.5. Deep Vein Thrombosis
- 6.5.1. Global Heparin Calcium Market, by Deep Vein Thrombosis, by Region, 2019-2032 (USD million)
- 6.6. Pulmonary Embolism
- 6.6.1. Global Heparin Calcium Market, by Pulmonary Embolism, by Region, 2019-2032 (USD million)
- 6.7. Others
- 6.7.1. Global Heparin Calcium Market, by Others, by Region, 2019-2032 (USD million)
7. Global Heparin Calcium Market, by Distribution Channel
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Heparin Calcium Market, by Distribution Channel, 2019-2032 (USD million)
- 7.3. Hospital Pharmacies
- 7.3.1. Global Heparin Calcium Market, by Hospital Pharmacies, by Region, 2019-2032 (USD million)
- 7.4. Retail Pharmacies
- 7.4.1. Global Heparin Calcium Market, by Retail Pharmacies, by Region, 2019-2032 (USD million)
- 7.5. Online Pharmacies
- 7.5.1. Global Heparin Calcium Market, by Online Pharmacies, by Region, 2019-2032 (USD million)
8. Global Heparin Calcium Market, by Geography
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Heparin Calcium Market Assessment, By Geography, 2019-2032 (USD million)
- 8.3. Heparin Calcium Market - North America
- 8.3.1. North America: Heparin Calcium Market, by Type, 2019-2032 (USD million)
- 8.3.2. North America: Heparin Calcium Market, by Application, 2019-2032 (USD million)
- 8.3.3. North America: Heparin Calcium Market, by Distribution Channel, 2019-2032 (USD million)
- 8.3.4. Heparin Calcium Market - U.S.
- 8.3.4.1. U.S.: Heparin Calcium Market, by Type, 2019-2032 (USD million)
- 8.3.4.2. U.S.: Heparin Calcium Market, by Application, 2019-2032 (USD million)
- 8.3.4.3. U.S.: Heparin Calcium Market, by Distribution Channel, 2019-2032 (USD million)
- 8.3.5. Heparin Calcium Market - Canada
- 8.3.5.1. Canada: Heparin Calcium Market, by Type, 2019-2032 (USD million)
- 8.3.5.2. Canada: Heparin Calcium Market, by Application, 2019-2032 (USD million)
- 8.3.5.3. Canada: Heparin Calcium Market, by Distribution Channel, 2019-2032 (USD million)
- 8.4. Heparin Calcium Market - Europe
- 8.4.1. Europe: Heparin Calcium Market, by Type, 2019-2032 (USD million)
- 8.4.2. Europe: Heparin Calcium Market, by Application, 2019-2032 (USD million)
- 8.4.3. Europe: Heparin Calcium Market, by Distribution Channel, 2019-2032 (USD million)
- 8.4.4. Heparin Calcium Market - UK
- 8.4.4.1. UK: Heparin Calcium Market, by Type, 2019-2032 (USD million)
- 8.4.4.2. UK: Heparin Calcium Market, by Application, 2019-2032 (USD million)
- 8.4.4.3. UK: Heparin Calcium Market, by Distribution Channel, 2019-2032 (USD million)
- 8.4.5. Heparin Calcium Market - France
- 8.4.5.1. France: Heparin Calcium Market, by Type, 2019-2032 (USD million)
- 8.4.5.2. France: Heparin Calcium Market, by Application, 2019-2032 (USD million)
- 8.4.5.3. France: Heparin Calcium Market, by Distribution Channel, 2019-2032 (USD million)
- 8.4.6. Heparin Calcium Market - Germany
- 8.4.6.1. Germany: Heparin Calcium Market, by Type, 2019-2032 (USD million)
- 8.4.6.2. Germany: Heparin Calcium Market, by Application, 2019-2032 (USD million)
- 8.4.6.3. Germany: Heparin Calcium Market, by Distribution Channel, 2019-2032 (USD million)
- 8.4.7. Heparin Calcium Market - Italy
- 8.4.7.1. Italy: Heparin Calcium Market, by Type, 2019-2032 (USD million)
- 8.4.7.2. Italy: Heparin Calcium Market, by Application, 2019-2032 (USD million)
- 8.4.7.3. Italy: Heparin Calcium Market, by Distribution Channel, 2019-2032 (USD million)
- 8.4.8. Heparin Calcium Market - Spain
- 8.4.8.1. Spain: Heparin Calcium Market, by Type, 2019-2032 (USD million)
- 8.4.8.2. Spain: Heparin Calcium Market, by Application, 2019-2032 (USD million)
- 8.4.8.3. Spain: Heparin Calcium Market, by Distribution Channel, 2019-2032 (USD million)
- 8.4.9. Heparin Calcium Market - Netherlands
- 8.4.9.1. Netherlands: Heparin Calcium Market, by Type, 2019-2032 (USD million)
- 8.4.9.2. Netherlands: Heparin Calcium Market, by Application, 2019-2032 (USD million)
- 8.4.9.3. Netherlands: Heparin Calcium Market, by Distribution Channel, 2019-2032 (USD million)
- 8.4.10. Heparin Calcium Market - Russia
- 8.4.10.1. Russia: Heparin Calcium Market, by Type, 2019-2032 (USD million)
- 8.4.10.2. Russia: Heparin Calcium Market, by Application, 2019-2032 (USD million)
- 8.4.10.3. Russia: Heparin Calcium Market, by Distribution Channel, 2019-2032 (USD million)
- 8.4.11. Heparin Calcium Market - Rest of Europe
- 8.4.11.1. Rest of Europe: Heparin Calcium Market, by Type, 2019-2032 (USD million)
- 8.4.11.2. Rest of Europe: Heparin Calcium Market, by Application, 2019-2032 (USD million)
- 8.4.11.3. Rest of Europe: Heparin Calcium Market, by Distribution Channel, 2019-2032 (USD million)
- 8.5. Heparin Calcium Market - Asia Pacific
- 8.5.1. Asia Pacific: Heparin Calcium Market, by Type, 2019-2032 (USD million)
- 8.5.2. Asia Pacific: Heparin Calcium Market, by Application, 2019-2032 (USD million)
- 8.5.3. Asia Pacific: Heparin Calcium Market, by Distribution Channel, 2019-2032 (USD million)
- 8.5.4. Heparin Calcium Market - China
- 8.5.4.1. China: Heparin Calcium Market, by Type, 2019-2032 (USD million)
- 8.5.4.2. China: Heparin Calcium Market, by Application, 2019-2032 (USD million)
- 8.5.4.3. China: Heparin Calcium Market, by Distribution Channel, 2019-2032 (USD million)
- 8.5.5. Heparin Calcium Market - India
- 8.5.5.1. India: Heparin Calcium Market, by Type, 2019-2032 (USD million)
- 8.5.5.2. India: Heparin Calcium Market, by Application, 2019-2032 (USD million)
- 8.5.5.3. India: Heparin Calcium Market, by Distribution Channel, 2019-2032 (USD million)
- 8.5.6. Heparin Calcium Market - Malaysia
- 8.5.6.1. Malaysia: Heparin Calcium Market, by Type, 2019-2032 (USD million)
- 8.5.6.2. Malaysia: Heparin Calcium Market, by Application, 2019-2032 (USD million)
- 8.5.6.3. Malaysia: Heparin Calcium Market, by Distribution Channel, 2019-2032 (USD million)
- 8.5.7. Heparin Calcium Market - Japan
- 8.5.7.1. Japan: Heparin Calcium Market, by Type, 2019-2032 (USD million)
- 8.5.7.2. Japan: Heparin Calcium Market, by Application, 2019-2032 (USD million)
- 8.5.7.3. Japan: Heparin Calcium Market, by Distribution Channel, 2019-2032 (USD million)
- 8.5.8. Heparin Calcium Market - Indonesia
- 8.5.8.1. Indonesia: Heparin Calcium Market, by Type, 2019-2032 (USD million)
- 8.5.8.2. Indonesia: Heparin Calcium Market, by Application, 2019-2032 (USD million)
- 8.5.8.3. Indonesia: Heparin Calcium Market, by Distribution Channel, 2019-2032 (USD million)
- 8.5.9. Heparin Calcium Market - South Korea
- 8.5.9.1. South Korea: Heparin Calcium Market, by Type, 2019-2032 (USD million)
- 8.5.9.2. South Korea: Heparin Calcium Market, by Application, 2019-2032 (USD million)
- 8.5.9.3. South Korea: Heparin Calcium Market, by Distribution Channel, 2019-2032 (USD million)
- 8.5.10. Heparin Calcium Market - Australia
- 8.5.10.1. Australia: Heparin Calcium Market, by Type, 2019-2032 (USD million)
- 8.5.10.2. Australia: Heparin Calcium Market, by Application, 2019-2032 (USD million)
- 8.5.10.3. Australia: Heparin Calcium Market, by Distribution Channel, 2019-2032 (USD million)
- 8.5.11. Heparin Calcium Market - Rest of Asia Pacific
- 8.5.11.1. Rest of Asia Pacific: Heparin Calcium Market, by Type, 2019-2032 (USD million)
- 8.5.11.2. Rest of Asia Pacific: Heparin Calcium Market, by Application, 2019-2032 (USD million)
- 8.5.11.3. Rest of Asia Pacific: Heparin Calcium Market, by Distribution Channel, 2019-2032 (USD million)
- 8.6. Heparin Calcium Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Heparin Calcium Market, by Type, 2019-2032 (USD million)
- 8.6.2. Middle East & Africa: Heparin Calcium Market, by Application, 2019-2032 (USD million)
- 8.6.3. Middle East & Africa: Heparin Calcium Market, by Distribution Channel, 2019-2032 (USD million)
- 8.6.4. Heparin Calcium Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Heparin Calcium Market, by Type, 2019-2032 (USD million)
- 8.6.4.2. Saudi Arabia: Heparin Calcium Market, by Application, 2019-2032 (USD million)
- 8.6.4.3. Saudi Arabia: Heparin Calcium Market, by Distribution Channel, 2019-2032 (USD million)
- 8.6.5. Heparin Calcium Market - UAE
- 8.6.5.1. UAE: Heparin Calcium Market, by Type, 2019-2032 (USD million)
- 8.6.5.2. UAE: Heparin Calcium Market, by Application, 2019-2032 (USD million)
- 8.6.5.3. UAE: Heparin Calcium Market, by Distribution Channel, 2019-2032 (USD million)
- 8.6.6. Heparin Calcium Market - Israel
- 8.6.6.1. Israel: Heparin Calcium Market, by Type, 2019-2032 (USD million)
- 8.6.6.2. Israel: Heparin Calcium Market, by Application, 2019-2032 (USD million)
- 8.6.6.3. Israel: Heparin Calcium Market, by Distribution Channel, 2019-2032 (USD million)
- 8.6.7. Heparin Calcium Market - South Africa
- 8.6.7.1. South Africa: Heparin Calcium Market, by Type, 2019-2032 (USD million)
- 8.6.7.2. South Africa: Heparin Calcium Market, by Application, 2019-2032 (USD million)
- 8.6.7.3. South Africa: Heparin Calcium Market, by Distribution Channel, 2019-2032 (USD million)
- 8.6.8. Heparin Calcium Market - Rest of Middle East & Africa
- 8.6.8.1. Rest of Middle East & Africa: Heparin Calcium Market, by Type, 2019-2032 (USD million)
- 8.6.8.2. Rest of Middle East & Africa: Heparin Calcium Market, by Application, 2019-2032 (USD million)
- 8.6.8.3. Rest of Middle East & Africa: Heparin Calcium Market, by Distribution Channel, 2019-2032 (USD million)
- 8.7. Heparin Calcium Market - Latin America
- 8.7.1. Latin America: Heparin Calcium Market, by Type, 2019-2032 (USD million)
- 8.7.2. Latin America: Heparin Calcium Market, by Application, 2019-2032 (USD million)
- 8.7.3. Latin America: Heparin Calcium Market, by Distribution Channel, 2019-2032 (USD million)
- 8.7.4. Heparin Calcium Market - Mexico
- 8.7.4.1. Mexico: Heparin Calcium Market, by Type, 2019-2032 (USD million)
- 8.7.4.2. Mexico: Heparin Calcium Market, by Application, 2019-2032 (USD million)
- 8.7.4.3. Mexico: Heparin Calcium Market, by Distribution Channel, 2019-2032 (USD million)
- 8.7.5. Heparin Calcium Market - Brazil
- 8.7.5.1. Brazil: Heparin Calcium Market, by Type, 2019-2032 (USD million)
- 8.7.5.2. Brazil: Heparin Calcium Market, by Application, 2019-2032 (USD million)
- 8.7.5.3. Brazil: Heparin Calcium Market, by Distribution Channel, 2019-2032 (USD million)
- 8.7.6. Heparin Calcium Market - Argentina
- 8.7.6.1. Argentina: Heparin Calcium Market, by Type, 2019-2032 (USD million)
- 8.7.6.2. Argentina: Heparin Calcium Market, by Application, 2019-2032 (USD million)
- 8.7.6.3. Argentina: Heparin Calcium Market, by Distribution Channel, 2019-2032 (USD million)
- 8.7.7. Heparin Calcium Market - Rest of Latin America
- 8.7.7.1. Rest of Latin America: Heparin Calcium Market, by Type, 2019-2032 (USD million)
- 8.7.7.2. Rest of Latin America: Heparin Calcium Market, by Application, 2019-2032 (USD million)
- 8.7.7.3. Rest of Latin America: Heparin Calcium Market, by Distribution Channel, 2019-2032 (USD million)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Pfizer Inc.
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Type Benchmarking
- 10.1.4. Recent Development
- 10.2. Sanofi S.A.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Type Benchmarking
- 10.2.4. Recent Development
- 10.3. Leo Pharma A/S
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Type Benchmarking
- 10.3.4. Recent Development
- 10.4. Teva Pharmaceutical Industries Ltd.
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Type Benchmarking
- 10.4.4. Recent Development
- 10.5. Sandoz (a division of Novartis)
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Type Benchmarking
- 10.5.4. Recent Development
- 10.6. Fresenius Kabi
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Type Benchmarking
- 10.6.4. Recent Development
- 10.7. Baxter International Inc.
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Type Benchmarking
- 10.7.4. Recent Development
- 10.8. Aspen Pharmacare
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Type Benchmarking
- 10.8.4. Recent Development
- 10.9. B. Braun Melsungen AG
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Type Benchmarking
- 10.9.4. Recent Development
- 10.10. Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Type Benchmarking
- 10.10.4. Recent Development
- 10.11. Hikma Pharmaceuticals PLC
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Type Benchmarking
- 10.11.4. Recent Development
- 10.12. Dr. Reddy's Laboratories
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Type Benchmarking
- 10.12.4. Recent Development
- 10.13. Cipla Limited
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Type Benchmarking
- 10.13.4. Recent Development
- 10.14. Bioiberica S.A.U.
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Type Benchmarking
- 10.14.4. Recent Development
- 10.15. Troikaa Pharmaceuticals Ltd.
- 10.15.1. Company Overview
- 10.15.2. Financial Performance
- 10.15.3. Type Benchmarking
- 10.15.4. Recent Development
